Bioretec
2,4
EUR
+2,13 %
BRETEC
First North Finland
Medical Equipment & Services
Health Care
1.517 følger denne virksomhed
+2,13%
+7,14%
0%
+4,35%
-10,45%
+6,67%
-2,04%
-
-18,38%
Bioretec is a medical technology company. The company specializes in the development of medical devices. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other material for bone and soft tissue injuries. In addition to the main business, service and associated ancillary services are also offered. Bioretec operates worldwide with the largest presence in the Nordic region.
Læs mereMarkedsværdi
56,01 mio. EUR
Aktieomsætning
37,76 t EUR
P/E (adj.) (25e)
-11,99
EV/EBIT (adj.) (25e)
-13,72
P/B (25e)
11,06
EV/S (25e)
8,14
Udbytteafkast, % (25e)
-
Omsætning og EBIT-margin
Omsætning mio.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
21.3
2025
Generalforsamling '25
15.5
2025
Selskabsgennemgang Q1'25
14.8
2025
Delårsrapport Q2'25
Risiko
Business risk
Valuation risk
Lav
Høj
ViserAlle indholdstyper
CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec
Bioretec Ltd's Financial Statements 2024 published
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth in 2024 - CE mark received in January 2025
Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe
Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2025
Bioretec Ltd's schedule for financial reporting in 2025
The Finnish Financial Supervisory Authority has imposed a penalty payment on a member of Bioretec's Board of Directors for late notification of managers' transactions
